Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

Naoki Sato,1,2 Yuya Nakamura,1,3 Shiho Yamadera,4 Masahiro Inagaki,1,5 Sachiyo Kenmotsu,5 Hiroshi Saito,4,6 Tatsunori Oguchi,1 Mayumi Tsuji,1 Hirokazu Chokki,1 Isao Ohsawa,3 Hiromichi Gotoh,3 Shinichi Iwai,6 Yuji Kiuchi1 1Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Sato N, Nakamura Y, Yamadera S, Inagaki M, Kenmotsu S, Saito H, Oguchi T, Tsuji M, Chokki H, Ohsawa I, Gotoh H, Iwai S, Kiuchi Y
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	linagliptin lipopolysaccharide lipopolysaccharide-binding protein interleukin-6 intranuclear subunit of nuclear factor-κB/p65 intracellular reactive oxygen species Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/71a3fb4bd53e4f08ac724daa0c043192
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

Documents similaires